IMSECMA
Live / Registered — Registered (as of 25 Aug 2026)
What this means for you
Registered since 25 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 25 Aug 2032: the §71 affidavit of use).
Record
- Serial number
- 79440140
- Registration number
- 8407840
- Mark type
- Word mark
- Filed
- 21 Nov 2025
- Published for opposition
- 07 Jul 2026
- Registered
- 25 Aug 2026
- Next maintenance filing
- §71 affidavit of use, due by 25 Aug 2032 (grace period to 25 Feb 2033)
- Attorney of record
- Kisuk Lee
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of inflammatory diseases; monoclonal antibodies for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of spondylitis; pharmaceutical preparations for the treatment of hidradenitis suppurativa.
Owner
- CELLTRION, INC., KR
- CELLTRION, INC., KR
- CELLTRION, INC., KR
Prosecution history
- 25 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
- 07 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jul 2026 — PUBLISHED FOR OPPOSITION
- 01 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 May 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 May 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 May 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 29 May 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 29 May 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 May 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 May 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 May 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Apr 2026 — REFUSAL PROCESSED BY IB